AstraZeneca enters Philippine market for cancer patients

AstraZeneca enters Philippine market for cancer patients with groundbreaking developments on new oral medicine. Revolutionary drug Olaparib…

PH FDA approves new treatment for Kidney Disease

The Philippine Food and Drug Administration (FDA) has approved a new treatment indication of Dapagliflozin for…